Clinical trials
Observational Hypercholesterolemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Recruiting | 3 |
| Withdrawn | 3 |
| Unknown status | 2 |
| Suspended | 1 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 6 |
| Massachusetts General Hospital | 2 |
| Novartis | 2 |
| Ohio State University | 2 |
| ProgenaBiome | 2 |
| BioKier Inc. | 1 |
| Boston Children's Hospital | 1 |
| Daxor Corporation | 1 |
| Duke University | 1 |
| Genomas, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 31 |
| Atherosclerosis | 5 |
| Hyperlipidemias | 5 |
| Hypertension | 5 |
| Cardiovascular Diseases | 4 |
| Dyslipidemias | 4 |
| Diabetes Mellitus | 3 |
| Colorectal Neoplasms | 2 |
| Coronary Disease | 2 |
| Heart Diseases | 2 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.